PCSK9 and atherosclerosis: A Chinese group recently reported that the combination of polycosanol and atorvastatin in atherosclerosis patients could attenuate the statin-induced elevation of serum Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) levels [25].